期刊文献+

宫颈细胞DNA检测筛查宫颈病变1510例体会

Cervical Cell DNA Detection in the Screening of Cervical Lesions in 1510 Cases
下载PDF
导出
摘要 目的探讨DNA定量分析检查在宫颈病变筛查中的应用价值。方法对2013年1月~12月我科门诊1510例患者宫颈脱落细胞进行DNA定量分析,以活检的病理组织学诊断为金标准,分析该种方法对诊断宫颈病变的临床意义。结果DNA异倍体细胞的检出率为33.84%;其中异常倍体细胞出现3个以上患者189例占12.51%,以3个以上DNA异倍体出现作为活检标准,并经患者知情同意行宫颈活检109例,宫颈病变的检查阳性70例,检出率为64.22%。结论细胞DNA定量分析检测敏感性高,适用于宫颈早期病变的筛查。 Objective To investigate the inspection application value in screening of cervical lesions of DNA quantitative analysis.Methods From 2013 to January^12 months in our department 1510 patients of cervical exfoliated cellDNA quantitative analysis to biopsy,pathological diagnosis as the gold standard,the clinical significance of this method for the diagnosis of cervical lesions.Results The detection of DNA aneuploid cellrate is 33.84%;the aneuploidy cells appeared more than 3 patients 189 cases accounted for 12.51%,with more than 3 DNA aneuploidy as biopsy criteria,and the informed consent of patients underwent cervical biopsy in 109 cases,cervical lesions,70 cases were positive,the detection rate of 64.22%.Conclusion Cell DNA quantitative analysis and detection sensitivity,screening for early cervical lesions.
作者 颜敏 YAN Min(Department of Gynaecology and Obstetrics,The Affiliated Baiyun Hospital of Guiyang Medical College,Guiyang 550014,Guizhou,China)
出处 《医学信息(医学与计算机应用)》 2014年第11期462-463,共2页 Medical Information
关键词 宫颈细胞DNA检测 宫颈癌前病变 Detection of cervical cellDNA Cervical precancerous lesions
  • 相关文献

参考文献2

二级参考文献19

  • 1孙小蓉,李玉兰,车东媛,晏想成,凌慧芳,凃洪章,汪键.用细胞DNA定量分析方法进行宫颈癌普查的临床研究[J].诊断病理学杂志,2005,12(1):12-16. 被引量:67
  • 2蔡小兰,单守勤,姚建云,侯方高.细胞DNA定量分析法在宫颈癌及癌前病变筛查中的应用[J].第二军医大学学报,2007,28(8):926-927. 被引量:7
  • 3Parkin DM, Bray FI, Devesa SS 2000. International Agency for Cancer burden in the year Research on Cancer-IARC Screening Group. Accuracy of screening test[ J]. Eur J Cancer 2001, 37(8) : $4-66.
  • 4Sudbo J, Lippman SM, Lee JJ, et al. The influence of resection and aneuploidy on mortality in oral leukoplakia [ J ]. N Engl J Med, 2004, 35 (14) : 1405 - 1413.
  • 5Sudbo J, Reith A. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention [ J ]. Int J Cancer, 2005, 115(3) :339 -345.
  • 6Sankaranarayanan R, Gaffikin L, Jacob M, et al. A critical assessment of screening methods for cervical neoplasia [ J]. Int J Gynecol Obstet, 2005,89(2) :S4 -S12.
  • 7Benedet JL, Anderson GH. Cervical intraepithelial neoplasia in British Columbia: a comprehensive program for detection, diagnosis, and treatment [ J ]. Gyneeol Oneol, 1981, 12 (2) : s280 - 291.
  • 8Davey E, Barratt A, Irwig L, et al. Effect of study design and quality oh unsatisfactory rates, cytology classification, and accuracy in liquid-based versus conventional cervical cytology: a systematic review'[ J ]. Lancet, 2006, 367 (9505) : 122 - 132.
  • 9Bulk S, Berkhof J, Bulkmans NW, et al. Preferential risk of HPV16 for squamous cell carcinoma and of HPV 18 for adenocareinoma of the cervix compared to women with normal cytology in the Netherlans [ J ]. Br J Cancer, 2006,94 ( 1 ) : 171 - 175.
  • 10Wright TC, Schiffman M. Adding a test for human papillomavirus DNA to cervical cancer screening[J]. N Engl J Med, 2003, 348 (6) : 489 - 490.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部